MSD Korea names new director for Diversified Business Unit

Published: 2013-08-12 06:56:00

Updated: 2013-08-12 06:56:00

MSD Korea, the subsidiary of the U.S. pharmaceutical firm Merck & Co., announced today that Lim Kwang-heok was appointed director of its Diversified Business Unit as of Aug. 5, based on his background in the country.

Lim will be responsible for the company’s whole marketing and sales activitie...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK